Clinical Evidence for a Bacillus coagulans–Centered Probiotic Composition in Metabolic-Environment Regulation and Weight Management Among Overweight Adults

Anas Ziraoui; Sergei Antonov; Khalil Foster

doi:10.54691/6nv13g37

Clinical Evidence for a Bacillus coagulans–Centered Probiotic Composition in Metabolic-Environment Regulation and Weight Management Among Overweight Adults

Anas Ziraoui, Sergei Antonov, Khalil Foster

Frontiers in Humanities and Social Sciences, (2026), Vol.6, No.4, pp.42-48

Published: April 20, 2026

DOI: 10.54691/6nv13g37

PDF: Download Full Text PDF

Abstract

Background: We sought to produce a ready manuscript on a Bacillus coagulans-centered probiotic composition while preserving the original quantitative matrix and figures associated with the composition. Methods: We integrated published randomized trials and evidence syntheses on Bacillus coagulans-containing interventions with the composition-linked comparative matrix retained in the manuscript package. Results: Published human evidence shows that probiotic interventions can produce modest but reproducible reductions in body weight, body mass index, waist circumference and selected metabolic markers over 8-12 weeks, particularly at adequate dose and duration [1-8]. Direct Bacillus coagulans-related trials support reductions in visceral fat, body weight or subgroup weight loss, whereas SCFA-oriented analyses support the biological plausibility of insulin-sensitivity improvement [2,3,8]. The retained composition-linked comparative matrix showed the same directional pattern across body weight, waist circumference, body fat, triglycerides, HOMA-IR, fecal SCFA index and responder rate. Conclusions: When read together, published clinical trials and the preserved composition-linked quantitative matrix support a coherent translational rationale for this Bacillus coagulans-based weight-management formulation.

Keywords: Bacillus coagulans; weight management; obesity; probiotics; SCFA; metabolic regulation.

APA Citation: Anas Ziraoui, Sergei Antonov, Khalil Foster (2026). Clinical Evidence for a Bacillus coagulans–Centered Probiotic Composition in Metabolic-Environment Regulation and Weight Management Among Overweight Adults. Frontiers in Humanities and Social Sciences, 6(4), 42-48. https://doi.org/10.54691/6nv13g37

References

Sudha MR, Ahire JJ, Neelamraju J, et al. Effect of multi-strain probiotic (UB0316) in weight management in overweight/obese adults: a 12-week double blind, randomised, placebo-controlled study. Benef Microbes. 2019;10(8):855-866.
Cho E, Kim JY, Cho B, et al. Efficacy of fermented grain using Bacillus coagulans in reducing visceral fat among people with obesity: a randomized controlled trial. Front Nutr. 2023;10:1148512.
Wang R, Wang X, Song X, et al. Effect of Bacillus coagulans BC99 supplementation on body weight and gut microbiota in overweight and obese individual: a randomized, double-blind, placebo-controlled study. Front Nutr. 2025;12:1542145.
Madempudi RS, Ahire JJ, Neelamraju J, et al. Efficacy of UB0316, a multi-strain probiotic formulation in patients with type 2 diabetes mellitus: a double blind, randomized, placebo controlled study. PLoS One. 2019;14(11):e0225168.
Pontes KSS, de Souza M, et al. Effects of probiotics on body adiposity and cardiovascular risk markers in individuals with overweight and obesity: a systematic review and meta-analysis of randomized controlled trials. Clin Nutr. 2021;40(8):4915-4931.
Musazadeh V, Zarezadeh M, et al. Anti-obesity properties of probiotics: findings from an umbrella meta-analysis. Clin Nutr ESPEN. 2022;49:125-134.
Cao N, Liu H, et al. Impact of probiotics on weight loss, glucose and lipid metabolism in overweight or obese women: a meta-analysis of randomized controlled trials. J Nat Sci Med. 2024;7:241-249.
Pham NHT, Joglekar MV, Wong WKM, et al. Short-chain fatty acids and insulin sensitivity: a systematic review and meta-analysis. Nutr Rev. 2024;82(2):193-209.